French pharmacy
Oligostim Trace Elements Copper Gold Silver Granions 40 tablets (Cu-Au-Ag), is a drug used in adults as a field modifier, in particular during the convalescence phase of infectious diseases , asthenic states (state of weakness, general fatigue, pronounced exhaustion).
The drug Oligostim Copper Gold Silver Granions sublingual tablets is specially developed based on trace elements, it is recommended in a therapeutic context of a modification of the ground, more particularly during a period of convalescence from infectious diseases and asthenic states ( large tired ).
This Oligostim drug delivers for 1 single tablet, 0.220 mg of copper gluconate, corresponding to 0.031 mg of copper, gold powder of 0.098 mg and finally 0.070 mg of colloidal silver, these active ingredients are the main components of this formula . The other active ingredients are lactose, croscarmellose A, magnesium stearate. These trace elements are essential for the well-being of the body and their supplementation is essential because we cannot synthesize them.
These trace elements give a boost to your body by fighting against winter ailments, an additional supply of trace elements is important for the proper functioning of the body.
If your symptoms persist, consult your doctor.
Take 1 to 2 tablets per day, in the morning on an empty stomach or away from meals. Let the tablet dissolve under the tongue.
Oligostim Copper Gold Silver Cu-Au-Ag Granions is formulated with:
Copper gluconate 0.220 mg, corresponding amount of copper 0.031 mg, gold powder 0.098 mg, colloidal silver 0.070 mg
Excipients: lactose, croscarmellose A, magnesium stearate
Excipient with known effect: lactose
What are the side effects and contraindications?
Presentation
Granions Oligostim Trace Elements Copper Gold Silver 40 tablets comes in the form of a box of 40 sublingual tablets.
No one had the slightest idea of the use of trace elements in therapy 50 years ago. Today, most doctors are convinced of the effectiveness of oligotherapy in various pathologies, and especially in functional pathologies. In 1942, Jacques Ménétrier, presenting the interest that the use of mineral elements could represent in human medicine, studied their therapeutic impact and identified the…
Read the article on the blog
